Skip to content

Insider · CIK 0001534261

Casdin Capital, LLC

directorowner

Files at BLFS (BIOLIFE SOLUTIONS INC), LAB (STANDARD BIOTOOLS INC.), WGS (GeneDx Holdings Corp.), TSVT (2seventy bio, Inc.). First filing Aug 22, 2025, latest Aug 22, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $60M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

WGS: GeneDx Holdings Corp.

WGSOct 9, 2026 · close 67.33

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
60Notable
WGSsell 3
GeneDx Holdings Corp.
$60M
500,000 shares
-14%+265% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 22, 2025WGS
GeneDx Holdings Corp.
SOpen-market sale
Class A Common Stockindirect: See footnote
-500,000$120.90$60M3,007,164Aug 22, 2025
May 13, 2025TSVT
2seventy bio, Inc.
UTender of shares
Common Stock, par value $0.0001 per share
-22,625$5.00$113k0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
UTender of shares
Common Stock, par value $0.0001 per shareindirect: See footnote
-2,000,000$5.00$10M0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
DDisposition to issuer
Stock Options (Right to buy)derivative
-12,050--0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
DDisposition to issuer
Stock Options (Right to buy)derivative
-33,400--0May 15, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.